Abstract
Anthracyclines are effectively used in many therapeutic regimens for breast cancer (BC). However, the dose-dependent cardiotoxic effect causes certain limitations on their use. Laboratory tests for risk prediction and early diagnosis of anthracycline-induced cardiotoxicity (ACIC) based on measuring the activity and concentration of topoisomerase 2β, the levels of troponins T and I (TnT и TnI), N-terminal fragment of brain natriuretic peptide progenitor, remain relevant, but complicate the risk stratification with low specificity. Recently, the number of works devoted to the study of new biomarkers ACIC has been growing: galectin-3, soluble ST-2 (sST-2), and myeloperoxidase (MPO). In this review we analyzed current understanding of the classical markers ACIC and the results of recent studies dedicated to new predictors.
PMID: 32163687 [PubMed - as supplied by publisher]
12:22
Photo
Not included, change data exporting settings to download.
256×256, 6.0 KB
12:22
In reply to this message
pubmed: ctoall&ca or conall
Religious observance and perceptions of end-of-life care.
Related Articles
Religious observance and perceptions of end-of-life care.
Nurs Inq. 2020 Mar 12;:e12347
Authors: Tarabeih M, Bokek-Cohen Y, Abu Rakia R, Nir T, Coolidge NE, Azuri P
No comments:
Post a Comment
اكتب تعليق حول الموضوع